Transfection of the Na+/I- symporter gene into tumors for radioiodide therapy
-
Abstract
Na+/I- symporter is a membrane glycoprotein that catalyzes the active accumulation of I-. The abnormality of NIS gene will lead to thyroid disease. We had succeeded in transfecting the Na+/I- symporter into tumors for radioiodide concentration. However, the effective half life is too short to acquire therapeutic dose. So we should research into prolonging the effective half-life and increased effective transfection.
-
-